Last reviewed · How we verify
NCT06627725
The Effect of Patient-Family Communication Via Audio Recording
NA trial testing Patient-Family Communication in Anxiety in 55 participants. Completed in 10 June 2023.
10 June 2023
Quick facts
| Lead sponsor | Yasemin Kalkan Uğurlu |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 55 |
| Start date | 10 May 2022 |
| Primary completion | 10 June 2023 |
| Estimated completion | 10 June 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Patient-Family Communication
Conditions studied
- Anxiety — all drugs for Anxiety →
- Anxiety Depression (Mild or Not Persistent) — all drugs for Anxiety Depression (Mild or Not Persistent) →
- Satisfaction With Care — all drugs for Satisfaction With Care →
Sponsor
Yasemin Kalkan Uğurlu
Who can join
18 and older, any sex, with Anxiety or Anxiety Depression (Mild or Not Persistent). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study was conducted as a randomized controlled blinded study. The sample consisted of 55 patient relatives (27 in the experimental group and 28 in the control group). The patient's relatives in the experimental group said what they wanted to say to their patient in line with the content determined by the researchers and recorded it using a voice recorder. The researcher played the recorded message to the patient, and the patient's feedback was conveyed to the patient's relative.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06627725
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety
Currently open trials in the same condition.
- NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
- NCT07522944 — AI-Guided Relaxation for Hemodialysis Anxiety · NA · recruiting
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT07425951 — Building Cognitive Behavioural Skills With StoryBooks to Reduce Emotional Difficulties in Kindergarten Years · NA · recruiting
- NCT07473505 — Integrative Bilateral Cervical Sympathetic Blocks for Trauma-Related Symptoms in Special Operations Veterans: A Prospect · recruiting
Other Yasemin Kalkan Uğurlu trials
Trials by the same sponsor.
- NCT04707586 — Lokal Cold Application in Nitroglycerin-Induced Headache (NIH) · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06627725 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Yasemin Kalkan Uğurlu
- Last refreshed: 4 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06627725.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing